Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
40.3M
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
27M
-
Shares change
-
+8.66M
-
Total reported value, excl. options
-
$81.6M
-
Value change
-
+$27.8M
-
Put/Call ratio
-
0
-
Number of buys
-
31
-
Number of sells
-
-21
-
Price
-
$3.02
Significant Holders of TELA Bio, Inc. - Common Stock (TELA) as of Q4 2024
64 filings reported holding TELA - TELA Bio, Inc. - Common Stock as of Q4 2024.
TELA Bio, Inc. - Common Stock (TELA) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27M shares
of 40.3M outstanding shares and own 67.11% of the company stock.
Largest 10 shareholders include Essex Woodlands Management, Inc. (4.11M shares), Nantahala Capital Management, LLC (3.68M shares), SILVERARC CAPITAL MANAGEMENT, LLC (3.07M shares), AIGH Capital Management LLC (2.66M shares), Stonepine Capital Management, LLC (2.35M shares), VANGUARD GROUP INC (1.88M shares), DAFNA Capital Management LLC (1.44M shares), ROYCE & ASSOCIATES LP (1M shares), Pentwater Capital Management LP (1M shares), and PERKINS CAPITAL MANAGEMENT INC (908K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.